|
|
Volumn 4, Issue , 1986, Pages 681-709
|
|
Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INTERLEUKIN 2;
LYMPHOKINE;
ANIMAL;
CLINICAL TRIAL;
DRUG TOLERANCE;
EXPERIMENTAL NEOPLASM;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
KILLER CELL;
LYMPHOCYTE;
LYMPHOCYTE ACTIVATION;
METHODOLOGY;
MOUSE;
NEOPLASM;
PASSIVE IMMUNIZATION;
RAT;
REVIEW;
ANIMALS;
CLINICAL TRIALS;
DRUG TOLERANCE;
HUMANS;
IMMUNIZATION, PASSIVE;
IMMUNOTHERAPY;
INTERLEUKIN-2;
KILLER CELLS;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTES;
LYMPHOKINES;
MICE;
NEOPLASMS;
NEOPLASMS, EXPERIMENTAL;
RATS;
|
|
EID: 0022605668
PISSN: 07320582
EISSN: None
Source Type: Journal
DOI: 10.1146/annurev.iy.04.040186.003341 Document Type: Review |
|
Times cited : (295)
|
|
References (73)
|
